INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer & Holzer, LLC

/EIN News/ -- ATLANTA, March 25, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether CorMedix Inc. (“CorMedix” or the “Company”) (NASDAQ: CRMD) complied with federal securities laws. On March 25, 2025, Cormedix reported fourth quarter and full year 2024 financial results. During the Company’s earnings call held the same day, Cormedix noted that “we do expect to begin to see some net price erosion beginning in the second quarter of 2025.” Following this news, the price of the Company’s stock dropped. 

If you purchased CorMedix stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com/case/cormedix/ to discuss your legal rights.

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.  

CONTACT:  
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com